INTRODUCTION
Hyperpolarized (HP) 129 Xe MRI has gained interest ever since the first image was acquired from a biological sample (1) . Xenon, when inhaled into the lungs, dissolves into the blood by diffusive gas exchange across the alveolar-capillary membrane (2) (3) (4) (5) (6) . The fraction that dissolves in the blood is determined by the xenon bloodgas partition coefficient (7, 8) , ratio of ventilated airspace volume to pulmonary blood volume (9) , capillary perfusion and alveolar surface-area-to-volume ratio. In the bloodstream, dissolved HP 129 Xe is transported to distal organs by the systemic blood circulation. The longitudinal relaxation time T 1 of HP 129 Xe in the human blood is sufficiently long (6 s to 8 s for arterial-oxygenated blood and 3 s to 4 s for venous-deoxygenated blood) for it to be detected in the distal organs (10) (11) (12) (13) .
Recently, studies involving NMR spectroscopy and chemical shift imaging (CSI) of HP 129 Xe dissolved in the brain have been conducted in rats (14) (15) (16) (17) and in humans (4, 18) . Kershaw et al and Nakamura et al (19, 20) observed five peaks in 129 Xe spectra from the rat head, which they attributed to jaw muscle (187-191 ppm), white matter (191-194 ppm) , gray matter (193-197 ppm) , fat tissue outside the brain (197-201 ppm), and red blood cells (210 ppm). The feasibility of imaging rat brain using HP 129 Xe CSI was demonstrated by Swanson et al (16) . Using HP 129 Xe, Mazzanti et al (14) explored the possibility of detecting increased brain perfusion and functional activity following sensory stimulation in rats and Zhou et al (15) demonstrated the detection of ischemic stroke in rats. To our understanding, the only two studies of HP 129 Xe in the human head to date are from Mugler et al (4) and Kilian et al (18, 21) who presented time resolved spectra depicting the uptake of HP 129 Xe into the human brain in vivo. Subsequently, Kilian et al (18, 21) reported preliminary results of HP 129 Xe CSI in the human brain at 3.0 Tesla (T) and estimated T 1 relaxation of HP 129 Xe dissolved in gray matter and white matter to be 14 s and 8 s, respectively.
Unlike the HP 129 Xe studies conducted in rats (19, 20) , the preliminary human studies have revealed two dissolved peaks which were attributed to gray matter (196 ppm) and white matter (193 ppm) (18, 21) , and one report showed evidence of a third peak at 186 ppm (21) . Thus, the motivation of our study at 1.5T was to perform (i) high resolution 129 Xe spectroscopy of the human head in vivo and (ii) CSI to spatially resolve the compartments of the brain responsible for the peaks observed.
METHODS

RF Coil and Calibration
For the construction of a custom 129 Xe radiofrequency (RF) coil for the human head, a rigid mechanical former was recycled from a disused 1 H head birdcage coil. An eight-leg birdcage coil of band pass topology was constructed with a capacitance of 289.5 pF (270 pF þ 18 pF þ 1.5 pF) and 1000 pF on the legs and on the end ring, respectively, as shown in Figure 1b . A photograph of the RF birdcage coil is shown in Figure 1a . The end ring diameter was 305 mm and the leg length was 300 mm as shown in Figure 1a . The capacitors used were of 10C package (Dalian Dalicap Technology Co., Ltd, Dalian, China). The birdcage coil was driven in quadrature transmit-receive mode. RF measurements were performed using an Agilent 5061B Network Analyzer (Keysight Technologies, Santa Rosa, CA).
The RF power required to achieve a desired flip angle was calculated based on a standard calibration procedure, whereby the rate of depletion of polarization of HP 129 Xe resulting from repeated acquisitions using hard RF pulse within a short time-interval (TR ( T 1 ) was fit to cos n-1 a, where n is the number of repeated acquisitions and a is the flip angle for the transmit RF power. To calculate the variation in flip angle across the coil, a plastic tube with 6 mm inner diameter was filled with HP 129 Xe and positioned radially within the RF coil as shown in the photograph in Figure 1c , and the coil was loaded with a standard nickel chloride (NiCl 2 Á6H 2 0:H 2 0) phantoms. The length of the tube was 36 cm, which covered the diameter of the RF coil.
Using a fast spoiled gradient echo sequence with a soft (Gaussian) RF pulse, with frequency encoding applied only along one direction (anterior to posterior as shown in Figure 1c ), the flip angle profile along the diameter of the RF coil was calculated by measuring the depletion of polarization of the HP 129 Xe in each voxel along the length of the tube as shown in Figure 1d . Acquisition parameters were: echo time (TE) ¼ 3.6 ms, repetition time (TR) ¼ 18.9 ms, matrix ¼ 1 (phase) Â 44 (frequency), slice thickness ¼ 200 mm, number of slices ¼ 1, field of view (FOV) ¼ 44 cm, RF pulse duration ¼ 800 ms, and the acquisition lasted 800 ms. A total of 39 repeated acquisitions were performed. T 1 relaxation and gas diffusion were both neglected for the calculation.
MRI Methods
All in vivo NMR with 129 Xe experiments were performed with approval from the UK National Research Ethics Committee under a protocol for the evaluation of novel MRI methods for imaging hyperpolarized xenon in the lungs, brain, and heart of healthy human volunteers. MRI experiments were performed on a GE whole-body 1.5T SignaV R HDx scanner. All in vivo experiments were conducted following inhalation of isotopically enriched xenon (87% 129 Xe) from 1 L TedlarV R bags. 129 Xe gas was polarized using spin exchange optical pumping to around 25% polarization (22) . Chemical shift values were calibrated with respect to the resonance of 129 Xe in the gas-phase measured in a TedlarV R bag positioned at the isocenter of the scanner. In vivo experiments were conducted on three healthy male volunteers with the mean age of 29 years and standard deviation of 3 years.
Wideband Spectroscopy
The xenon gas dose for the acquisition was 1 L. The acquisition was performed under breath-hold commencing immediately after the inhalation of the gas and lasted for 20 s thereafter. After inhalation, the residual gas in the TedlarV R bag was placed on the neck of the subject to obtain a reference HP 129 Xe gas-phase signal. A total of 20 discrete free induction decays (FIDs) were acquired with a flip angle of 20 and TR of 1 s. The transmit RF pulse was a hard pulse with a pulse duration of 500 ms. The center frequency was set to 197.93 ppm downfield (17,660,800 Hz) from the 129 Xe gas-phase resonance and the receiver bandwidth was 674.16 ppm (11.9 kHz). The spectral resolution was 0.16 ppm (2.9 Hz) with 4096 sampling points in the spectrum. All 20 acquired complex spectra were averaged to improve the signal-to-noise ratio (SNR). No spectral line broadening filters were applied.
High Resolution Spectroscopy
For high resolution spectroscopy, data acquisition was performed during a 20 s breath-hold, commencing 4 s after inhalation of a 1 L dose of xenon gas. Ten discrete FIDs were acquired with a TR of 2 s and a flip angle of 45
. The transmit RF pulse was a hard pulse with a pulse duration of 500 ms. The center frequency was set to 197.93 ppm downfield (17,660,800 Hz) from the 129 Xe gas-phase resonance and the receiver bandwidth was 136.09 ppm (2403 Hz). The spectral resolution was 0.033 ppm (0.58 Hz) with 4096 sampling points in the spectrum. All 10 acquired complex spectra were averaged and no spectral line broadening filters were applied.
Chemical Shift Imaging
To spatially localize the 129 Xe spectral peaks anatomically in the human brain, 2D CSI was conducted by applying phase-encoding in the anterior-posterior and right-left directions for axial-plane CSI, anteriorposterior and superior-inferior directions for sagittalplane CSI, and right-left and superior-inferior directions for coronal-plane CSI. FIDs were acquired for each phase-encoding step using a pulse-acquire sequence without slice selection. The transmit RF pulse was as described earlier. The center frequency was set to 197.93 ppm downfield (17,660,800 Hz) from the 129 Xe gas-phase resonance and the receiver bandwidth was 136.05 ppm (2403 Hz). The spectral resolution was 2.1 ppm (37 Hz) with 64 sampling points per spectrum. The flip angle was 10 , and the TR was 45 ms. For a matrix size of 12 Â 12 and a FOV of 24 cm, 144 phase-encoded spectra were acquired with an effective in-plane spatial resolution of 20 mm Â 20 mm. The acquisition was performed under breath-hold, commencing 16 s after the inhalation of a 1 L dose of xenon gas and lasted for 6.5 s thereafter. No spectral line broadening filters were applied. For anatomical reference, 1 H MR images were acquired (in each of the three anatomical planes) using an inversion recovery gradient echo pulse sequence in a separate scan with the same FOV as the 129 129 Xe CSI represents the maximum value of a particular chemical shift peak at that spatial location. An image intensity threshold determined by visual inspection was applied to the 2D CSI images of dissolved HP 129 Xe to eliminate background noise. The threshold for each of the 2D CSI images were determined and applied individually.
RESULTS
RF Coil and Calibration
The quality factor (Q) of the birdcage RF coil in the unloaded condition was 270 and in the loaded condition was 86. The ratio of the Q factor in unloaded to loaded condition was, therefore, 3.1. The isolation (transfer coefficient, S ij; i6 ¼j ð Þ ) between the in-phase and the quadraturephase ports of the RF birdcage coil was lower than À15 dB. Figure 1d RF pulse, the standard deviation of the flip angle measured across the diameter of the coil was 5.9 (6.56%) and the flip angle profile is shown in Figure 1d .
Spectroscopy
An averaged spectrum of HP 129 Xe dissolved in the human head acquired with a wide receiver bandwidth is shown in Figure 2a . The spectrum exhibits two distinct peaks near 0 ppm assigned to 129 Xe in the gaseous phase. Near the center frequency of the spectrum, five distinct dissolved 129 Xe peaks from the human head can be observed, at 188.4 ppm, 192.7 ppm, 195.6 ppm, 199.6 ppm, and 217.2 ppm.
An averaged whole head spectrum acquired from HP 129 Xe dissolved in the human head with high spectral resolution (0.033 ppm) is shown in Figure 2b 
Chemical Shift Imaging
To demonstrate that the SNR of spatially resolved spectra from the CSI experiment of the human head are sufficient, example spectra (at arbitrary locations) for each of the anatomical planes are shown in Figure 3 . It can be observed, that the SNR of these spatially resolved spectra are sufficient to enable distinction of the peaks at 188 ppm, 192 ppm, 196 ppm, 200 ppm, and 217 ppm, and that the signal amplitudes are clearly prominent above the noise floor. Spatially resolved spectra in all the three imaging planes superimposed on corresponding anatomical 1 H images are shown in Figure 4 . Chemical shift images corresponding to 129 Xe NMR peak from the head at 188 ppm, 192 ppm, 196 ppm, 200 Figure 5d shows the spectrum from Figure 2b split into its constituent real and imaginary parts after zeroth order phase-correction using the 195.4 ppm (gray matter) peak as a reference. The full width half maximum of the peak at 195.4 ppm (gray matter) in Figure 5d is 36 Hz.
DISCUSSION
In Figure 2a , the peak at À0.7 ppm can be attributed to residual gas in the TedlarV R bag placed on the subject's neck. The 129 Xe gas-phase resonance being shifted by À0.7 ppm (instead of 0 ppm) suggests B 0 variation of 1 mT due to the TedlarV R bag not being positioned at the isocenter of the magnet combined with bulk susceptibility shifts related to the subject's head. Similarly, we postulate that the peak at À2.8 ppm is related to detection of 129 Xe gas in the smaller airways of the lungs in the stray field of the RF coil. The upfield (negative) chemical shift of this 129 Xe gas in the smaller airways of the lungs could be due to a combination of effects, including; bulk magnetic susceptibility shift effects (5), the chemical shift associated with mixing with oxygen (23) and the fact that while an average adult head is positioned at the isocenter, the lungs lie further away from the isocenter at a lower static magnetic field strength than the isocenter and would experience a lower Larmor frequency.
The chemical shift values reported in Figure 3 are marginally different from the values reported in Figure 2 , most likely due to the considerable difference in spectral resolution between the two acquisitions. In addition, it can be observed that some of the five peaks (from Figure  2) are absent in some of the spectra in Figure 3 . This indicates that the particular biochemical compartment giving rise to a specific chemical shift value is not present at that particular voxel location.
From the anatomical location of the 129 Xe NMR peaks in the chemical shift images superimposed on corresponding 1 H images in Figure 5 , we propose the assignment of each individual peak to a particular compartment of the head as follows: From Figure 5a , the peak at 188 ppm appears to be most intense in the anterior region of the axial plane image. The sagittal plane image indicates that most of the signal from this peak arises from regions below the eyes, above the jawline and between the nose and ears. In the coronal plane image, it is evident that the signal intensity is approximately symmetric on both right and left sides of the head. In addition, this image shows that some contribution arises from a location at the midbrain. We allocate the peak at 188 ppm to HP 129 Xe dissolved in soft muscular tissue in cheek and midbrain. From Figure 5b , it can be observed that the peak at 192 ppm appears to predominantly arise from 129 Xe dissolved in the brain. In the axial plane, the peak at 192 ppm is most intense in the brain with some evidence of tracts. Similarly, in the coronal plane image, the peak at 192 ppm appears to be most intense in the central brain, again with some evidence of tracts. In the sagittal plane image, a contribution to the 192 ppm peak can be observed from 129 Xe in the region of the nasal cavity. Thus, it can be postulated that the peak at 192 ppm corresponds to HP 129 Xe dissolved in white matter (Commissural and Projection tracts) and cartilaginous soft-tissue. Figure 5c shows that the 129 Xe peak at 196 ppm is predominantly localized to the brain; it can be clearly seen in images from the all three anatomical planes that the peak not only emanates from the brain, but does not appear anywhere else. Thus it can be concluded that the peak at 196 ppm corresponds to HP 129 Xe dissolved in the gray matter.
ppm
Unlike the case of xenon gas in an isolated bag, in the human brain in vivo, 129 Xe will undergo diffusive chemical exchange with other compartments of the brain that come in to contact with each other (such as cerebral blood, interstitial fluid, and cerebrospinal fluid). Existence of any such chemical exchange will broaden the line-width of the NMR peaks of the compartments under exchange. Nevertheless, under these conditions the full width half maximum of a particular spectral peak will provide a lower limit estimate of the T 
From Figure 5e , the peak at 200 ppm appears to originate from 129 Xe located in the anterior region of the head, as seen from the axial plane image. In the sagittal plane image, most of the signal appears to be from regions among the eyes, nose, and ears, and extends below toward the jaw. In the coronal plane image, the signal appears to arise from the center of the head in the rightleft direction. In all the three anatomical planes, the signal appears to coincide with the location of the ventricles. Thus, the peak at 200 ppm is likely from HP 129 Xe dissolved in body interstitial fluid/plasma, fat tissue outside the brain, and cerebrospinal fluid.
From Figure 5f , in all three anatomical planes, the only location where the peak at 217 ppm shows considerable signal intensity is at the location of the Circle of Willis. This peak at 217 ppm can, therefore, be allocated to HP 129 Xe dissolved in the red blood cells. It is worth noting that this peak is broader than the others, most probably due to the diffusive chemical exchange between 129 Xe dissolved in various compartments, and to the fact that blood oxygenation will vary across the head, resulting in a dispersion of the chemical shift due to difference in the oxygenation state of the hemoglobin (24) .
The assignment of the chemical shift values with the particular biochemical environments as described above (18-21) ; 199.6 ppm, aqueous solution (cerebrospinal fluid, plasma, and interstitial fluid in this study) (10, 11, (24) (25) (26) and fat/lipid tissue outside the brain (19, 20) ; and 217.2 ppm, red blood cells (4, 10, 24, 26) .
The peaks seen in whole brain spectroscopy and their anatomical distribution from CSI, were found to be consistent between the subjects as shown in Figure 6 . The SNR of the obtained spectra was found to be somewhat variable between the subjects. As SNR is limited by the quantity and polarization of 129 Xe delivered to the brain by the systemic blood circulation, any variability in the polarization of the SEOP process, gas dose inhaled or T 1 losses related to different lung-to-brain transit times will affect the observed SNR. Assessment of these factors, their variability and their effect on measured spectroscopic SNR of dissolved 129 Xe in the brain is the subject of future work.
On closer inspection of Figure 2b , it can be seen that the peak at 187.2 ppm appears to be comprised of two closely spaced peaks at 186.7 ppm and 187.7 ppm which requires further investigation. In addition, a peak at 190.6 ppm can be observed in both Figure 2a inset and 2b which also requires further investigation in future work.
CONCLUSIONS
This is the first time that five distinct 129 Xe NMR peaks have been observed in the human head in vivo and we believe this to be the first report of 129 Xe CSI in the human head in vivo at 1.5T. Although earlier studies evidenced the presence of 5 129 Xe NMR peaks in the rat head (19, 20) , only two or three peaks have been previously detected from 129 Xe in the human head from spectra of significantly lower SNR and spectral resolution than those in this study (4, 18) . Our results should provide a useful reference for future 129 Xe NMR spectroscopy studies of the human brain. Furthermore, the methods established here may be directly applied to quantify the dynamics of xenon uptake into the human brain and probe the potential pathophysiological changes induced by functional abnormalities.
